Urology Imaging Systems Market

Urology Imaging Systems Market Outlook – 2022-2028

[236 Pages Report] Sales in the global Urology Imaging Systems Market are slated to top US$ 391.6 Mn in 2022. Expanding at a healthy 3.7% CAGR, the market size is projected to total US$ 486.4 Mn by 2028.

Attribute	Details
Urology Imaging Systems Market Estimated Size 2022	US$ 391.6 Million
Urology Imaging Systems Market Value-based CAGR (2022 to 2028)	~3.7%
Urology Imaging Systems Market Size in Projected 2028	US$ 486.4 Million

The rising prevalence of various urologic diseases, such as prostate problems, bladder control problems, kidney stones, and Urinary Tract Infections (UTI) is projected to boost the sales in this market. Coupled with this, the increasing cases of multiple sclerosis and Parkinson's disease amongst the geriatric population is set to drive the market in the upcoming years.

The ongoing development of handheld urology MRI scanners by various renowned manufacturers across the globe is estimated to spur the market. The market also will gain from the growing number of international resellers of refurbished and brand new urology imaging systems.

How The Market Progressed Till June 2022?

Particulars	Details
H1, 2021	3.78%
H1, 2022 Projected	3.68%
H1, 2022 Outlook	3.48%
BPS Change - H1, 2022 (O) – H1, 2022 (P)	(+) 04 ↑
BPS Change – H1, 2022 (O) – H1, 2021	(-) 30 ↓

As per the Future Market Insights’ analysis, the H1-2022 outlook period in comparison to H1-2022 projected period showed a surge in growth rate in terms of Basis Point Share by 04 BPS.

The surge in the BPS values observed can be associated with the development of 3d printing for novel equipment, as well as translation of medical imaging into tangible replicas of patient-specific anatomy. With growing enhancements in medical imaging systems, the market is set to experience a positive growth outlook.

However, In H1-2022 when compared to H1-2021, the market growth rate of urology imaging systems is expected to fall by 30 basis point share (BPS), as per FMI analysis. The resultant drop in the BPS values in are associated with the high costs associated with the MRI compatible urology imaging systems, as well as long procedural time, thus resulting in a fall in the adoption rate.

The market is subject to changes as per the macro and industry dynamics which include disease prevalence and epidemiology, device regulations, technology adoption, and product licensing and distribution.

Key developments in the market include the collaboration of 3D printing and additive manufacturing for imaging.

2013-2021 Urology Imaging Systems Market Outlook in Comparison to 2022-2028 Growth Forecast

The urology imaging systems market is expected to register 3.7% CAGR between 2022 and 2028, up from 3.8% CAGR recorded during 2013-2021, predicts Future Market Insights.

The increasing cases of kidney stones in various parts of the globe is one of the major factors bolstering the sales of urology imaging solutions. According to the National Kidney Foundation, from 2013 to 2014, the prevalence of kidney stones was 10% in the U.S., while in the late 2000s, it was 8.8%. It is likely to surge worldwide in the near future because of obesity, not drinking enough water, and consumption of sugar and protein-rich food and beverages.

Download Report Brochure

Focus of various governments towards the expansion of their healthcare infrastructure also will fuel the demand for urology scanners. The market is slated to gain from the growing number of innovative diagnostic centers and the high prevalence of chronic diseases.

The increasing geriatric population is often linked to the surging prevalence of bladder outlet obstruction, urological cancer, and urinary incontinence. As per a report published by the World Health Organization (WHO) in 2017, the prevalence of urinary incontinence reported in population-based studies ranges from 9.9% to 36.1%. The rate is twice as high in older women as in older men. This trend is likely to continue in the near future, thereby propelling the growth in this market.

Will the Prevalence of UTI and Kidney Stone Propel the Urology Imaging Systems Market?

The surging adoption of cutting-edge urology imaging solutions by non-radiologists is projected to push the growth in this market. Innovations in PC-based designs, miniaturization of ultrasound urology imaging systems, development of the narrow band imaging cystoscopy technology, and the easy access to instant clinical information are estimated to fuel the market in the forthcoming years.

Stone formation and infections in the tract are the two common urological diseases that are expected to increase in the future backed by the high consumption of red meat and alcohol, drinking inadequate amount of water, and lack of knowledge about urological hygiene post sexual intercourse.

The WHO mentioned that an estimated 50% of women report having had an UTI at some point in their lives and more than 1 million hospitalizations take place every year because of this condition worldwide. Thus, governments around the world are taking initiatives to conduct awareness programs to educate the general public about UTI and its treatment options, which is set to bolster the demand for urology imaging solutions.

Country-wise Insights

How Will the U.S. Urology Imaging Systems Market Fare?

“Rapid Adoption of Portable Urology Scanners to Drive the Market”

The rising adoption of portable urology scanners among non-radiology specialists in the U.S. is anticipated to drive the urology imaging systems market in North America. Also, the presence of various reputed healthcare device manufacturers, such as GE, Stryker Corporation, Boston Scientific Corporation, and Intuitive Surgical in the U.S. is projected to accelerate adoption of urology imaging systems.

In December 2021, for instance, Proton International, a leading provider of proton therapy to cancer patients based in Florida, signed a new contract with Belgium-based medical technology company, Ion Beam Applications S.A. As per this contract, Ion will install the former’s Proteus ONE proton therapy solution in its three-story Radiation Oncology Center.

The system will be equipped with a fully integrated Quality Assurance (QA) hardware and software package, Pencil Beam Scanning (PBS), hand pendant for easy patient positioning, and Cone Beam Computed Tomography (CBCT). Thus, the engagement of leading U.S.-based players in signing contracts with healthcare institutions of other countries is anticipated to spur the demand for urology scanners.

Why is the Japan Urology Imaging Systems Market Growing Steadily?

“Growing Incidence of Prostate Cancer to Boost Adoption of Narrow Band Imaging Cystoscopy”

The rapid expansion of the medical devices industry in Japan is likely to bolster the urology imaging systems market in East Asia during the evaluation period. The country has the highest number of the elderly population in this region. According to the World Bank data, in 2020, about 28.39% percent of Japan's population were aged 65 years and above. This number is projected to surge in the forthcoming years, thereby propelling the need for urology MRI scans.

Furthermore, the higher incidence rate of colorectal cancer and prostate cancer among the aging population is set to spur the market in Japan. The American Association for Cancer Research states that the incidence of prostate cancer surged to 58.7 in 2014 from 7.1 per 100,000 in 1975 in Japan. Driven by the abovementioned factors, the adoption of narrow band imaging cystoscopy technology is likely to grow in this country.

Which Factors are propelling the U.K. Urology Imaging Systems Market?

“Increasing Obese Population to Fuel the Demand for Urology MRI Scanners”

The increasing demand for cloud-based solutions with higher magnified visualization and portable urology MRI scanners equipped with novel software solutions in the U.K. is set to push the growth in Europe by 2028. Besides this, the presence of a well-established healthcare system in the U.K. is estimated to propel the market in the near future.

The increasing cases of obesity owing to the surging consumption of junk food and adoption of unhealthy lifestyles is anticipated to spur the market in the U.K. According to Cancer Research U.K., 1 in 6 men will get prostate cancer at some point in their lives in this country. The organization also mentions that being obese will increase the risk of advanced prostate cancer.  Thus, the prevalence of prostate cancer induced by obesity is set to rise in the U.K., which would bolster the market.

Category-wise Insights

Which is the Leading Product Type in the Urology Imaging Systems Market?

“High Accuracy Feature to Fuel Demand for Ultrasound Urology Imaging Solutions”

In terms of product type, the ultrasound systems segment is estimated to account for approximately 54.6% of the urology imaging systems market share in 2022, predicts FMI. The high reliability and accuracy provided by ultrasound systems in terms of diagnosis is anticipated to propel their demand in the assessment period.

The fluoroscopy-based systems will remain the second-leading segment, contributing around 45.4% of the market share till 2022, finds FMI. Unlike standard radiographs, fluoroscopy-based systems deliver images in an inverted grayscale. The ongoing evolution in the field of urology imaging solutions is projected to aid the development of advanced fluoroscopy-based systems with 3-D capabilities. This is likely to spur the segment’s growth.

Who is the Dominant End User in Urology Imaging Systems Market?

“Hospitals are Preferring Narrow Band Imaging Cystoscopy Technology”

Based on end user, the hospitals segment is anticipated to remain at the forefront in terms of the urology imaging systems market share. The surging demand for minimally invasive techniques owing to the need to shorten the length of hospital stay, reduce the infection rate, and lower the blood loss across the globe is likely to increase people’s preference for hospitals.

The increasing number of hospitals offering state-of-the-art medical services, such as narrow band imaging cystoscopy technology in both developed and emerging economies is expected to push the segment forward. Many renowned companies are tying up with hospitals worldwide to install their in-house solutions for providing better treatment options to patients. This will also emerge as a chief growth driver.

Competition Landscape

Some of the key players operating in the urology imaging systems market are focusing on the production of novel systems to cater to the high demand from patients across the globe. Other players are conducting extensive research and development activities to introduce technologically developed urology imaging solutions. A few of them are also participating in the acquisition strategy to expand their existing product portfolios and gain a competitive edge in the market.

For instance,

• In January 2022, Olympus, a manufacturer of optics and reprography products headquartered in Japan, published the findings of independent clinical studies in the Journal of Urology. The study found that the treatment of kidney stones with SOLTIVE Premium SuperPulsed Laser System can provide the potential for lower procedures costs, better patient outcomes, and shorter procedure times, as compared to those performed with Holmium: YAG.
• In January 2022, Promaxo, Inc., a medical imaging, robotics, and AI technology company based in California, sold its in-office MRI system to Kasraeian Urology. The U.S. FDA recently approved the company’s single-sided MRI system equipped with AI-based imaging for in-office use. It would enable hospitals and practices to seamlessly and accurately guide prostate interventions, thereby overcoming the limitations of conventional MRI systems.

Scope of Report

Attribute	Details
Forecast Period	2013 to 2021
Historical Data Available for	2022 to 2028
Market Analysis	Units for Volume and US$ Mn for Value
Key Regions Covered	North America; Latin America; Europe; East Asia; South Asia; India; and the Middle East & Africa.
Key Countries Covered	United States, Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others.
Key Market Segments Covered	Product Type, End Use, and Region
Key Companies Profiled	Philips Healthcare; GE Healthcare; Siemens Healthcare; Analogic Corporation; Esaote S.p.A.; Samsung Medison Co. Ltd.; FUJIFILM Holdings Corporation; Hitachi Medical Corporation; Toshiba Corporation; Mindray Medical International Limited
Pricing	Available upon Request

Urology Imaging Systems Market by Category

By Product Type:

• Ultrasound Systems
• Fluoroscopy-based Systems

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Diagnosis Centers
• Clinics

By Region:

• North America
• Latin America
• Europe
• Oceania
• East Asia
• South Asia
• Middle East & Africa (MEA)

Frequently Asked Questions

What is the global urology imaging systems market size?

The global urology imaging systems market is expected to reach a valuation of US$ 391.6 Mn in 2022.

At what rate did the global urology imaging systems market grow between 2013 and 2021?

The global urology imaging systems market grew at a healthy 3.8% CAGR between 2013 and 2021.

What are the key trends boosting sales of urology imaging systems?

The increasing prevalence of prostate cancer and the rising demand for minimally invasive techniques are the key trends boosting the sales of urology imaging systems.

Who are the leading urology imaging systems market players?

Philips Healthcare, GE Healthcare, Siemens Healthcare, Analogic Corporation, Esaote S.p.A., Samsung Medison Co. Ltd., FUJIFILM Holdings Corporation, and Hitachi Medical Corporation are some of the leading players present in the global urology imaging systems market.

What is the share of the ultrasound systems segment in the urology imaging systems market?

The ultrasound systems segment is anticipated to account for 54.6% of the urology imaging systems market share in 2022.

What is the share of the fluoroscopy-based systems segment in the urology imaging systems market?

The fluoroscopy-based systems segment is projected to account for 45.4% of the urology imaging systems market share in the forecast period.